Valneva Announces Major COVID-19 Vaccine Partnership with U.K. Government – GlobeNewswire

· UK Government has secured supply of 60 million doses at a cost of 470 million with options over another 130 million doses between 2022 and 2025

• UK Government invests in Valnevas manufacturing facility in Livingston, Scotland, to support scale up, creating major UK vaccine facility
• Inactivated, adjuvanted, two-dose SARS-COV-2 vaccine candidate scheduled to enter first clinical studies in December 2020
  • Combines Valnevas proven approach with Dynavax CpG 1018 adjuvant

  <... Click here to view the original article.